Navigation Links
Irregular Menses and Pain Caused by Adenomyosis or Endometriosis Can Be Improved with Herbal Therapy without Pain Killers & Surgeries - Wuhan Dr. Lee’s TCM Clinic
Date:5/21/2013

(PRWEB) May 21, 2013

It is typical that women with adenomyosis or endometriosis experience a notable improvement of symptoms, especially irregular menses and pain, after about three months medication with patented herbal therapy from Wuhan Dr. Lee’s TCM Clinic, global.fuyanpills.com reveals.

Adenomyosis and endometriosis are both the disorder of endometrium, the inner line of the uterus. They’re extremely common, yet are still affecting lots of sufferers as one of the top causes of infertility in women. "Surgical and hormonal treatment of endometriosis and adenomyosis have unpleasant side effects and high rates of relapse," reveals Lewith G on pubmed.gov. "In China, treatment of endometriosis using Chinese herbal medicine (CHM) is routine and considerable research into the role of CHM in alleviating pain, promoting fertility, and preventing relapse has taken place. Following laparoscopic surgery women who were given Chinese herbs were reported to have comparable benefits to women with conventional drug treatments."

Chief doctor of Wuhan Dr. Lee’s TCM Clinic, Dr. Lee Xiaoping states, "Our herbal medicine Fuyan Pill has been benefiting thousands of women with endometrial disorders every year in China during the past 10 years, and have been taken by hundreds of oversea patients since 2 years ago when I’ve got it patented in SIPO (State Intellectual Property Office of China)."

The clinic has been recording the details of patients reviews since the year 2010, and the latest data (April 2013) from Wuhan Dr. Lee’s TCM Clinic shows that over 92% of patients have reported improvement after one month medication, over 60% of the patients get their condition completely cured after 3 months, about 23% of them need 4 months, only a small group may need a longer time in recovery.

"The most noticeable advantage of our herbal therapy is that it has no side effect at all," adds Dr. Lee. When asking about the key to this consummation, "a herb named ‘liquorice’ is the magic code, it reduces the toxicity of other herbs so that the formula is much more safer and brings no damage to the body at all," says Dr. Lee.

One of Dr. Lee’s patient, Clarissa P from Canada says, "I’ve finished two months pills and the herbs have made a huge difference. I’ve had a 5 cm adenomyosis before 2 months ago and I have had a HSG test recently which shows the cyst is only 2 cm. Dr. Lee suggested me to take 2 more months pills to clear that up. I’m grateful, it was worth every penny!"

Now this herbal formula is available online, for more details, please visit global.fuyanpills.com.

About Dr.Lee Xiaoping and the herbal medicine: Dr.Lee Xiaoping graduated from Hubei College of Traditional Chinese Medicine, China. She qualified as a herbalist 30 years ago and is a highly experienced medical professional. She specializes in the field of male and female reproductive and urinary system diseases. She has devoted 30 years to her clinic and worked on the formula of Fuyan Pill for years. The medicine has proven to be effective on treating tubal conditions. The formula is patented by SIPO (State Intellectual Property Office of the P.R.C) with the application number 201110031968.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10744110.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Outside the box: UCLA uses brain aneurysm treatment to stop irregular heart rhythms
2. Symptoms and care of irregular heartbeats differ by gender
3. Antidepressants Celexa, Lexapro Tied to Irregular Heartbeat: Study
4. Irregular heart beat elevates risk of kidney failure
5. Fish Oil Supplements Wont Prevent Irregular Heart Beat: Study
6. Overactive Thyroid May Raise Risk for Common Irregular Heartbeat
7. Fish Oil Wont Prevent Irregular Heartbeat After Cardiac Surgery: Study
8. More Patients With Irregular Heartbeat Recognize Stroke Risk: Survey
9. Irregular Heartbeat May Pose Higher Stroke Risk for Women Than Men
10. Asthma Meds May Be Linked to Irregular Heartbeat
11. Elderly women with irregular heart beat at higher risk for stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... weight management program at Women’s Excellence will help patients lose weight and keep ... exam. The specialists at Women's Excellence will measure BMI, body fat composition, ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... nurses and supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. ... Bundles.” , “Increasingly, supply chain and value analysis professionals have a ‘seat ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is ... complicated and require expert user knowledge. In a live webinar on April 11th ... simplified, yet highly accurate, determination of sodium. , It has long been known ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... with opioids alone responsible for over 33,000 of the 52,404 drug-related deaths in ... Bill (AB) 1512, which proposes a tax on prescription opioids to fund drug ...
(Date:3/25/2017)... ... March 25, 2017 , ... Getting earned media coverage meaningful for ... , All through the year, Garden Media aims to provide material helpful to ... influencers and pitching client’s key messages to gain coveted media placements, Garden ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing ... children, today reported financial results for the fourth ... and provided an update on its corporate activities. ... during the fourth quarter of 2016 through the ... study, and with our lead development candidate, PRX-OTC, ...
Breaking Medicine Technology: